262 related articles for article (PubMed ID: 7841300)
21. Paris I dysfibrinogenemia: a point mutation in intron 8 results in insertion of a 15 amino acid sequence in the fibrinogen gamma-chain.
Rosenberg JB; Newman PJ; Mosesson MW; Guillin MC; Amrani DL
Thromb Haemost; 1993 Mar; 69(3):217-20. PubMed ID: 8470043
[TBL] [Abstract][Full Text] [Related]
22. Three abnormal fibrinogen variants with the same amino acid substitution (gamma 275 Arg----His): fibrinogens Bergamo II, Essen and Perugia.
Reber P; Furlan M; Henschen A; Kaudewitz H; Barbui T; Hilgard P; Nenci GG; Berrettini M; Beck EA
Thromb Haemost; 1986 Dec; 56(3):401-6. PubMed ID: 3563970
[TBL] [Abstract][Full Text] [Related]
23. Fibrinogen Nový Jicín and Praha II: cases of hereditary Aalpha 16 Arg-->Cys and Aalpha 16 Arg-->His dysfibrinogenemia.
Kotlín R; Chytilová M; Suttnar J; Riedel T; Salaj P; Blatný J; Santrůcek J; Klener P; Dyr JE
Thromb Res; 2007; 121(1):75-84. PubMed ID: 17408725
[TBL] [Abstract][Full Text] [Related]
24. Fibrinogen Oviedo I. A new Spanish dysfibrinogenaemia.
Fernández FJ; Rodríguez Pinto C; Páramo J; Cuesta B; Collado M; Rocha E
Blood Coagul Fibrinolysis; 1990 Oct; 1(4-5):571-5. PubMed ID: 2133236
[TBL] [Abstract][Full Text] [Related]
25. Fibrinogen Longmont. A heterozygous abnormal fibrinogen with B beta Arg-166 to Cys substitution associated with defective fibrin polymerization.
Lounes KC; Lefkowitz JB; Coates AI; Hantgan RR; Henschen-Edman A; Lord ST
Ann N Y Acad Sci; 2001; 936():129-32. PubMed ID: 11460470
[TBL] [Abstract][Full Text] [Related]
26. Fibrinogen Matsumoto III: a variant with gamma275 Arg-->Cys (CGC-->TGC)--comparison of fibrin polymerization properties with those of Matsumoto I (gamma364 Asp-->His) and Matsumoto II (gamma308 Asn-->Lys).
Terasawa F; Okumura N; Higuchi Y; Ishikawa S; Tozuka M; Ishida F; Kitano K; Katsuyama T
Thromb Haemost; 1999 May; 81(5):763-6. PubMed ID: 10365751
[TBL] [Abstract][Full Text] [Related]
27. A case of congenital afibrinogenemia: fibrinogen Hakata, a novel nonsense mutation of the fibrinogen gamma-chain gene.
Iida H; Ishii E; Nakahara M; Urata M; Wakiyama M; Kurihara M; Watanabe K; Kai T; Ihara K; Kinoshita S; Hamasaki N
Thromb Haemost; 2000 Jul; 84(1):49-53. PubMed ID: 10928469
[TBL] [Abstract][Full Text] [Related]
28. A frameshift mutation in Exon V of the A alpha-chain gene leading to truncated A alpha-chains in the homozygous dysfibrinogen Milano III.
Furlan M; Steinmann C; Jungo M; Bögli C; Baudo F; Redaelli R; Fedeli F; Lämmle B
J Biol Chem; 1994 Dec; 269(52):33129-34. PubMed ID: 7806542
[TBL] [Abstract][Full Text] [Related]
29. Fibrinogen Milano XII: a dysfunctional variant containing 2 amino acid substitutions, Aalpha R16C and gamma G165R.
Bolliger-Stucki B; Lord ST; Furlan M
Blood; 2001 Jul; 98(2):351-7. PubMed ID: 11435303
[TBL] [Abstract][Full Text] [Related]
30. Fibrinogen Kiel: a congenital dysfibrinogenaemia with (A alpha-16 Arg----His) substitution characterized by HPLC without prior isolation of fibrinogen.
Seydewitz HH; Gram J; Bruhn HD; Witt I
Blood Coagul Fibrinolysis; 1991 Aug; 2(4):501-6. PubMed ID: 1768762
[TBL] [Abstract][Full Text] [Related]
31. Novel fibrinogen mutation (gamma 313 Ser-->Asn) associated with hypofibrinogenemia in two unrelated families.
Meyer M; Bergmann F; Brennan SO
Blood Coagul Fibrinolysis; 2006 Jan; 17(1):63-7. PubMed ID: 16607083
[TBL] [Abstract][Full Text] [Related]
32. Abnormal fibrinogens IJmuiden (B beta Arg14----Cys) and Nijmegen (B beta Arg44----Cys) form disulfide-linked fibrinogen-albumin complexes.
Koopman J; Haverkate F; Grimbergen J; Engesser L; Nováková I; Kerst AF; Lord ST
Proc Natl Acad Sci U S A; 1992 Apr; 89(8):3478-82. PubMed ID: 1565641
[TBL] [Abstract][Full Text] [Related]
33. The mutation in fibrinogen Bicêtre II (gamma Asn308-->Lys) does not affect the binding of t-PA and plasminogen to fibrin.
Grailhe P; Boyer-Neumann C; Haverkate F; Grimbergen J; Larrieu MJ; Anglés-Cano E
Blood Coagul Fibrinolysis; 1993 Oct; 4(5):679-87. PubMed ID: 8292717
[TBL] [Abstract][Full Text] [Related]
34. Fibrinogen Alès: a homozygous case of dysfibrinogenemia (gamma-Asp(330)-->Val) characterized by a defective fibrin polymerization site "a".
Lounes KC; Soria C; Mirshahi SS; Desvignes P; Mirshahi M; Bertrand O; Bonnet P; Koopman J; Soria J
Blood; 2000 Nov; 96(10):3473-9. PubMed ID: 11071644
[TBL] [Abstract][Full Text] [Related]
35. Fibrinogen Caracas V, an abnormal fibrinogen with an Aalpha 532 Ser-->Cys substitution associated with thrombosis.
Marchi R; Lundberg U; Grimbergen J; Koopman J; Torres A; de Bosch NB; Haverkate F; Arocha Piñango CL
Thromb Haemost; 2000 Aug; 84(2):263-70. PubMed ID: 10959699
[TBL] [Abstract][Full Text] [Related]
36. Functional analysis of recombinant Bbeta15C and Bbeta15A fibrinogens demonstrates that Bbeta15G residue plays important roles in FPB release and in lateral aggregation of protofibrils.
Hirota-Kawadobora M; Kani S; Terasawa F; Fujihara N; Yamauchi K; Tozuka M; Okumura N
J Thromb Haemost; 2005 May; 3(5):983-90. PubMed ID: 15869595
[TBL] [Abstract][Full Text] [Related]
37. A congenitally abnormal fibrinogen (Vlissingen) with a 6-base deletion in the gamma-chain gene, causing defective calcium binding and impaired fibrin polymerization.
Koopman J; Haverkate F; Briët E; Lord ST
J Biol Chem; 1991 Jul; 266(20):13456-61. PubMed ID: 2071611
[TBL] [Abstract][Full Text] [Related]
38. Fibrinogen Kanazawa: a congenital dysfibrinogenaemia with delayed polymerization having a replacement of proline-18 by leucine in the A alpha-chain.
Uotani C; Miyata T; Kumabashiri I; Asakura H; Saito M; Matsuda T; Kajiyama S; Iwanaga S
Blood Coagul Fibrinolysis; 1991 Jun; 2(3):413-7. PubMed ID: 1932527
[TBL] [Abstract][Full Text] [Related]
39. Dysfibrinogen Kagoshima with the amino acid substitution gammaThr-314 to Ile: analyses of molecular abnormalities and thrombophilic nature of this abnormal molecule.
Niwa K; Mimuro J; Miyata M; Sugo T; Ohmori T; Madoiwa S; Tei C; Sakata Y
Thromb Res; 2008; 121(6):773-80. PubMed ID: 17854865
[TBL] [Abstract][Full Text] [Related]
40. A C-terminal amino acid substitution in the gamma-chain caused by a novel heterozygous frameshift mutation (Fibrinogen Matsumoto VII) results in hypofibrinogenaemia.
Fujihara N; Haneishi A; Yamauchi K; Terasawa F; Ito T; Ishida F; Okumura N
Thromb Haemost; 2010 Aug; 104(2):213-23. PubMed ID: 20589319
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]